Martin Nutraceuticals Inc. Provides Shareholder Update.RENO, Nev. -- Mr. Harvey Panesar, President of Martin Nutraceuticals Inc. (PINKSHEETS:MNCL MNCL Maintenance Non-Computing (Module) Load ) reports that "from a corporate perspective, 2006 was a very full and exciting year for Martin Nutraceuticals Inc. In 2006, Martin Nutraceuticals was able to complete several of its key corporate objectives, which included retail exposure, a television campaign to support retail activities in Eastern Canada Eastern Canada (also the Eastern provinces) is the region of Canada generally considered to be east of Manitoba, consisting of the following provinces:
In 2006, Martin Nutraceuticals Inc. (MNI See Merom New Instructions. ) obtained numerous listings with several key retailers for its flagship products A primary product of a company, which is typically why the company was founded and/or what made it well known. For example, MS-DOS, Windows and the Microsoft Office suite have been flagship products of Microsoft. CorelDRAW is a flagship product of Corel Corporation. . These listings enabled MNI to build brand exposure and a retail presence while the company completed a television campaign geared for Quebec operations. Steady sales for MNI's flagship products continue as the company shifted focus in the second half of 2006 to concentrate on the launch of Dr. Martin's new book, Medical Crisis - Secrets Your Doctor Won't Share With You. The company made a corporate decision to change its marketing strategies by focusing on completing a Direct Response Television (DRTV) campaign to launch the Medical Crisis book in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. . Management strongly feels that the successful airing of the DRTV for the Medical Crisis book will result in increased retail demand of the company's flagship products going into the U.S. market. "We believe that the success of the book will be a great introduction to the fantastic products of Martin Nutraceuticals," states Mr. Panesar. "If the public is reading the book, it will give them a far better insight into how our products will contribute to their overall health." "The DRTV industry is a multi-billion dollar industry and we immediately added more credibility to what we are aiming to achieve by choosing a reputable firm like Opfer Communications to implement our DRTV campaign," continued Mr. Panesar. The company is hoping to run the test market for the DRTV campaign early in the second quarter of 2007. This will provide ratings and customer feedback for the company before the nationwide launch of the DRTV campaign in Q3 of 2007. One other key area which the company has been focusing on is the back-end solutions for the DRTV campaign. The company is very close to completing negotiations with call-center service providers and fulfillment centers which are an integral part of any DRTV campaign. Martin Nutraceuticals has been in the process of re-branding the online image of the company. "We realize that our online growth could possibly be a lucrative avenue and one that we are preparing to fully explore," states Mr. Panesar. "The online community does millions of dollars of purchases monthly and we fully intend to tap into this market." About Martin Nutraceuticals Inc. Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control. Arthrizyme(TM) is a unique blend of systemic enzymes proven to rapidly reduce inflammation in joints and muscles. Arthrizyme(TM) is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin fibrin: see blood clotting. in joints and muscles. Arthrizyme(TM) differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme(TM) is fast acting, usually improving symptoms within the first few days. For more information on the company, please contact investor relations Investor relations The process by which the corporation communicates with its investors. at (973) 351-3868. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement This release may contain forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. The risks and uncertainties that may affect the operations, performance development and results of the Company's business include but are not limited to fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion